Is Hashimoto's (autoimmune thyroiditis) disease an autoimmune disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Hashimoto's Disease an Autoimmune Disease?

Yes, Hashimoto's thyroiditis (also called chronic autoimmune thyroiditis) is definitively an autoimmune disease characterized by thyroid-specific autoantibodies and lymphocytic infiltration of the thyroid gland. 1, 2

Defining Characteristics of Hashimoto's as an Autoimmune Disease

Hashimoto's thyroiditis is the most common autoimmune thyroid disorder and represents the leading cause of hypothyroidism in iodine-sufficient regions worldwide. 2, 3

The autoimmune nature of Hashimoto's disease is established by several key features:

  • Autoantibody production: The disease is characterized by the presence of thyroid peroxidase (TPO) antibodies and/or thyroglobulin antibodies in the serum, which are the biochemical hallmarks of the condition 2, 4

  • Lymphocytic infiltration: Histopathologic examination reveals T and B cell inflammatory infiltration of the thyroid gland, with lymphoid follicle formation and germinal centers 2, 5

  • Loss of self-tolerance: The pathogenesis involves a breakdown of immunological tolerance mechanisms, leading to an autoimmune attack against thyroid tissue 3, 5

  • Cellular and humoral immunity: Both T-cell mediated cytotoxicity and antibody-mediated autoimmune responses drive the destruction of thyrocytes 2, 4

Clinical Recognition in Guidelines

Multiple international guidelines explicitly classify Hashimoto's thyroiditis as an autoimmune disease and the most common cause of hypothyroidism in pregnant and postpartum women in industrialized nations. 1

The American College of Obstetricians and Gynecologists (ACOG) identifies chronic autoimmune thyroiditis (Hashimoto's disease) as the most frequent cause of hypothyroidism in industrialized countries, distinguishing it from iodine deficiency which predominates worldwide 1

Association with Other Autoimmune Conditions

Hashimoto's thyroiditis frequently clusters with other autoimmune diseases, further confirming its autoimmune classification. 1

The Korean Association for the Study of the Liver reports that autoimmune thyroid disease is the most common concurrent autoimmune condition in patients with autoimmune hepatitis, with Hashimoto's thyroiditis accounting for approximately 10.2-14.1% of all concomitant autoimmune diseases 1

Type 1 autoimmune hepatitis is commonly associated with autoimmune thyroid disease, while type 2 autoimmune hepatitis is associated with type 1 diabetes and autoimmune thyroid disease 1

Approximately 20% of patients with autoimmune thyroid disorders have other organ-specific or systemic autoimmune conditions 3

Pathogenic Mechanisms

The autoimmune pathogenesis involves:

  • Genetic susceptibility: Strong hereditary predisposition confirmed by family and twin studies, with associations to HLA genes, CTLA-4, PTPN22, and other immune-related genes 5

  • Environmental triggers: Iodine intake, infections, drugs, and chemical exposures can precipitate disease in genetically susceptible individuals 1, 5

  • Immune dysregulation: Predominantly Th1 and Th17 immune responses lead to progressive thyroid destruction through apoptosis and cytotoxic mechanisms 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.

Best practice & research. Clinical endocrinology & metabolism, 2019

Research

Pathogenesis Markers of Hashimoto's Disease-A Mini Review.

Frontiers in bioscience (Landmark edition), 2022

Related Questions

What are the differential diagnoses and recommended lab tests for a patient with a complex presentation of transient rashes, joint hyperextensibility, possible urinary incontinence, neuropathy, and suspected Hashimoto's thyroiditis?
How should I manage a 28‑year‑old woman with Hashimoto’s thyroiditis and mild subclinical hypothyroidism, scalp psoriasis with photosensitivity, bloating that improves with dairy‑ and gluten‑avoidance, constipation, benign bilateral breast cysts (BIRADS 2), prior short‑term anxiolytic use now stopped, scoliosis managed with exercise, regular menstrual cycles, and a family history of gastric cancer?
What is Hashimoto's thyroiditis?
In a 35‑year‑old woman with new‑onset fatigue, generalized weakness and fluctuating ptosis over a few days, and a history of Hashimoto’s thyroiditis, what is the most likely diagnosis and how should it be managed in a primary‑care setting?
What causes Hashimoto's disease?
What is the recommended management for a patient with stage 2 endometrial cancer, considering the use of concurrent External Beam Radiation Therapy (EBRT) with chemotherapy?
What are the typical chest x-ray findings in a patient with Langerhans Cell Histiocytosis (LCH)?
Is it true that in patients with impaired glomerular filtration and significant proteinuria, protein loss leads to tubular injury, which in turn exacerbates glomerular damage?
How to safely discontinue mirtazapine (an antidepressant) 7.5 mg in an adult patient with a history of depression?
What is the recommended protocol for withdrawing cariprazine (atypical antipsychotic) in a patient with a history of psychiatric conditions?
What is the recommended management approach for a patient with stage II endometrial cancer, particularly those with high-risk features such as deep myometrial invasion, grade 3 histology, or serous/clear cell histology, in terms of External Beam Radiation Therapy (EBRT) and chemotherapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.